areta has a multipurpose GMP facility authorized by Italian Medicines Agency (AIFA) to produce and release biological products for clinical trials. The GMP plant has been designed with independent HVAC systems to simultaneously process different types of products. The authorization covers different classes of products: cells, biotechnological products, immunological products, DNA plasmids, aseptic fill and finishing and final lyophilization.

areta provides also safety and QC tests, biochemical and biological characterization, stability studies according ICH and final batch release services.